Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Trading update

3 Jul 2012 07:00

RNS Number : 7269G
Persimmon PLC
03 July 2012
 



 

 

TRADING UPDATE

 

TUESDAY 3 JULY 2012

 

 

Persimmon plc announces the following update ahead of its Half Year Results to 30 June 2012, which will be released on Tuesday 21 August 2012.

 

We legally completed 4,712 new homes (2011: 4,439) in the first six months of 2012, an increase of 6% on the prior year. Sales rates have continued to run ahead of 2011 through the Spring season, with weekly average private sales rate per site for the first half being c. 18% ahead. Turnover for the first half was c. £805 million, a c. 13% increase on the previous year. Cancellation rates remain at low levels in line with the prior year at c. 18%.

 

We have opened 65 new sites in the first half of the year and we are currently selling new homes from c. 375 sites. Visitor numbers to both the Persimmon Homes and Charles Church home finder web sites for the first six months are over 50% stronger than for the previous year. This reflects customers' growing preference to search for a new home using the internet and is driving healthy levels of visitors to our developments. We anticipate opening a further c. 60 new sites during the second half of the year which will continue to refresh our strong outlet network. In line with our long term strategy we remain focussed on maintaining the current strength of our site network to improve our capital efficiency and returns.

 

Our average selling price was 7% ahead year-on-year at c. £171,400 (2011: £160,583) reflecting a greater proportion of traditional family homes in the sales mix. Pricing has remained firm during the first half of the year.

 

At 30 June the value of our total forward sales of c. £774 million was c. 7% ahead of the prior year. This is a combination of our private sale forward revenue being c. 11% ahead of the same point last year whilst the value of forward sales to housing associations was in line with last year. We have experienced the normal seasonal slow down in private sales reservations from around the time of the Jubilee weekend as we move into the quieter summer weeks. 

 

Our long term strategy announced in February 2012 requires a continued improvement in margins and associated free cash generation. We anticipate underlying operating margins will have increased in the first half to more than 11.5% (2011: 9.0%). In addition, at 30 June 2012 our cash holdings totalled c. £135 million resulting from free cash inflows before dividends of c. £112 million during the first six months of the year (2011: 30 June borrowings of £15 million). 

 

Strong cash generation has supported significant investment in new land. We have invested c. £150 million in land in the first half and have acquired c. 5,600 new plots, increasing our consented land bank to c. 63,800 plots (June 2011: 62,364 plots). We continue to identify high quality sites at the required levels of return across the UK. Our land teams have delivered further strategic land conversion amounting to c. 1,700 plots, c. 30% of the new plots acquired in the period. These new sites will support the further development of the business over the years to come.

 

The Group's performance in the first half of the year represents an excellent start in the delivery of our new long-term strategic plan to develop the Group into a stronger, larger business, backed by a significant and high quality landbank whilst returning £1.9 billion (£6.20 per share) of capital to shareholders over the next nine years. The first capital payment of £227 million is anticipated in June 2013.

 

Whilst market conditions have been relatively stable during the first half of the year, sentiment within the UK housing market continues to be impacted by the continued weakness in the wider UK economy. However, we remain confident that we will be able to operate successfully in the current market and achieve our strategic objectives.

 

We will announce our Half Year Results on Tuesday 21 August 2012 and provide further details at that time.

 

Please Note

 

There will be a call for analysts at 0900 BST today. Please use the dial-in details below:

 

Telephone number: +44 (0)20 3003 2666

Conference code: Persimmon

 

An audiocast of the call will be available on www.corporate.persimmonhomes.com from this afternoon.

 

For further information please contact:

 

Mike Farley, Group Chief Executive

Simon Rigby

Mike Killoran, Group Finance Director

Kevin Smith

Persimmon plc

Lindsay Noton

Tel: +44 (0) 1904 642199

Citigate Dewe Rogerson

Tel: +44 (0) 20 7638 9571

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFMGGNVZVGZZM
Date   Source Headline
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.